Your browser doesn't support javascript.
loading
EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP).
Cardona, Andrés F; Rojas, Leonardo; Zatarain-Barrón, Zyanya Lucia; Freitas, Helano C; Granados, Sara T; Castillo, Omar; Oblitas, George; Corrales, Luis; Castro, Christian D; Ruiz-Patiño, Alejandro; Martín, Claudio; Pérez, María Angelina; González, Lisde; Chirinos, Luis; Vargas, Carlos; Carranza, Hernán; Otero, Jorge; Rodriguez, July; Rodriguez, Jenny; Archila, Pilar; Lema, Mauricio; Acosta Madiedo, José; Karachaliu, Niki; Wills, Beatriz; Pino, Luis E; de Lima, Vladimir; Rosell, Rafael; Arrieta, Oscar.
Afiliação
  • Cardona AF; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia; Clinical Research and Biology Systems Department, Universidad el Bosque, Bogotá, Colombia. Electronic address: a_cardonaz@yahoo.com.
  • Rojas L; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia; Clinical Research and Biology Systems Department, Universidad el Bosque, Bogotá, Colombia; Internal Medicine Department, Pontificia Universidad Javeriana, Bogotá, Colombia; Clinical Oncology Department, Clínica Colsanita
  • Zatarain-Barrón ZL; Thoracic Oncology Unit, National Cancer Institute (INCan), México City, Mexico.
  • Freitas HC; A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Granados ST; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia.
  • Castillo O; Instituto Oncológico Nacional, Panamá City, Panama.
  • Oblitas G; Hospital Oncológico Luis Razetti, Caracas, Venezuela.
  • Corrales L; Oncology Department, Hospital San Juan de Dios, San José Costa Rica, Costa Rica.
  • Castro CD; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia.
  • Ruiz-Patiño A; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia.
  • Martín C; Medical Oncology Group, Fleming Institute, Buenos Aires, Argentina.
  • Pérez MA; Hospital Oncológico Luis Razetti, Caracas, Venezuela.
  • González L; Arsuve, Caracas, Venezuela.
  • Chirinos L; Clínica de Prevención del Cáncer, Caracas, Venezuela.
  • Vargas C; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia; Clinical Research and Biology Systems Department, Universidad el Bosque, Bogotá, Colombia.
  • Carranza H; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia; Clinical Research and Biology Systems Department, Universidad el Bosque, Bogotá, Colombia.
  • Otero J; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia; Clinical Research and Biology Systems Department, Universidad el Bosque, Bogotá, Colombia.
  • Rodriguez J; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia.
  • Rodriguez J; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia.
  • Archila P; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia.
  • Lema M; Oncology Department, Clínica Astorga, Medellín, Colombia.
  • Acosta Madiedo J; Oncology Department, Clínica Porto Azul, Barranquilla, Colombia.
  • Karachaliu N; Translational Research Unit, Coyote Group, IOR/Dexeus University Hospital, Barcelona, Spain.
  • Wills B; Internal Medicine Department, Johns Hopkins University, Baltimore, Maryland, United States.
  • Pino LE; Oncology Department, Institute of Oncology, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
  • de Lima V; Thoracic Oncology Unit, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Rosell R; Personalized Medicine Program, Catalan Institute of Oncology - ICO, Barcelona, Spain.
  • Arrieta O; Thoracic Oncology Unit, National Cancer Institute (INCan), México City, Mexico.
Lung Cancer ; 125: 265-272, 2018 11.
Article em En | MEDLINE | ID: mdl-30429031
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hispânico ou Latino / Éxons / Adenocarcinoma de Pulmão / Neoplasias Pulmonares / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hispânico ou Latino / Éxons / Adenocarcinoma de Pulmão / Neoplasias Pulmonares / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article